Staar Surgical Company Profile (NASDAQ:STAA)

About Staar Surgical

Staar Surgical logoSTAAR Surgical Company designs, develops, manufactures and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The Company operates in the ophthalmic surgical market segment. Its principal products are intraocular lenses (IOLs) used in cataract surgery and implantable collamer lenses (ICLs) used in refractive surgery. It makes lenses used across the world in corrective or refractive surgery, and makes lenses for use in surgery that treats cataracts. Its refractive surgery corrects the types of visual disorders that glasses or contact lenses have treated (myopia, hyperopia, astigmatism and presbyopia). Its refractive surgery corrects the types of visual disorders that glasses or contact lenses have treated (myopia, hyperopia, astigmatism and presbyopia). It sells its products in approximately 60 countries, with direct distribution in the United States, Canada, Japan and Spain, and independent distribution in the remainder of the world.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Instruments & Supplies
  • Sub-Industry: Health Care Supplies
  • Exchange: NASDAQ
  • Symbol: STAA
  • CUSIP: 85231230
Key Metrics:
  • Previous Close: $9.25
  • 50 Day Moving Average: $9.27
  • 200 Day Moving Average: $7.48
  • 52-Week Range: $4.98 - $10.30
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 308.33
  • P/E Growth: -1.25
  • Market Cap: $373.99M
  • Outstanding Shares: 40,431,000
  • Beta: 1.26
  • Net Margins: -16.00%
  • Return on Equity: -7.12%
  • Return on Assets: -4.37%
  • Debt-to-Equity Ratio: 0.04%
  • Current Ratio: 2.40%
  • Quick Ratio: 1.63%
Additional Links:
Companies Related to Staar Surgical:

Analyst Ratings

Consensus Ratings for Staar Surgical (NASDAQ:STAA) (?)
Ratings Breakdown: 3 Hold Ratings, 1 Buy Rating
Consensus Rating:Hold (Score: 2.25)
Consensus Price Target: $6.50 (29.73% downside)

Analysts' Ratings History for Staar Surgical (NASDAQ:STAA)
DateFirmActionRatingPrice TargetDetails
8/4/2016William BlairReiterated RatingMarket PerformView Rating Details
5/18/2016Benchmark Co.UpgradeHold -> Buy$6.00View Rating Details
5/12/2016Canaccord GenuityReiterated RatingHold$7.00View Rating Details
5/12/2016StephensDowngradeOverweight -> Equal WeightView Rating Details
(Data available from 10/24/2014 forward)


Earnings History for Staar Surgical (NASDAQ:STAA)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/3/2016ListenView Earnings Details
8/3/2016Q216($0.05)($0.05)$19.88 million$21.00 millionViewListenView Earnings Details
5/11/2016Q116($0.17)($0.01)$19.60 million$19.30 millionViewListenView Earnings Details
3/2/2016Q415($0.02)$0.01$19.11 million$20.90 millionViewListenView Earnings Details
10/28/2015Q315($0.04)($0.04)$17.87 million$18.80 millionViewListenView Earnings Details
4/29/2015Q115($0.04)$0.03$17.85 million$18.90 millionViewListenView Earnings Details
2/25/2015Q414($0.05)($0.03)$16.60 million$16.60 millionViewListenView Earnings Details
10/30/2014Q314$0.02($0.04)$19.53 million$18.20 millionViewListenView Earnings Details
7/30/2014Q214$0.03$0.01$19.80 million$20.05 millionViewListenView Earnings Details
4/28/2014Q114$0.01$0.04$19.44 million$20.20 millionViewListenView Earnings Details
2/26/2014Q413$0.02$0.02$18.98 million$18.90 millionViewListenView Earnings Details
10/30/2013Q313$0.02$0.04$17.35 million$17.10 millionViewListenView Earnings Details
7/31/2013Q2 2013$0.04$0.05$17.40 million$18.20 millionViewListenView Earnings Details
5/1/2013Q1 2013$0.04$0.08$17.27 million$18.00 millionViewListenView Earnings Details
2/27/2013Q4 2012$0.03$0.01$17.55 million$16.50 millionViewListenView Earnings Details
10/31/2012Q312$0.01$0.04$16.78 million$15.90 millionViewN/AView Earnings Details
8/1/2012$0.03$0.03ViewN/AView Earnings Details
5/2/2012$0.03$0.04ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Staar Surgical (NASDAQ:STAA)
Current Year EPS Consensus Estimate: $-0.30 EPS
Next Year EPS Consensus Estimate: $0.03 EPS


Dividend History for Staar Surgical (NASDAQ:STAA)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Staar Surgical (NASDAQ:STAA)
Insider Ownership Percentage: 5.60%
Institutional Ownership Percentage: 74.20%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/29/2016Broadwood Partners LpMajor ShareholderBuy14,144$5.24$74,114.56View SEC Filing  
5/25/2016Broadwood Partners LpMajor ShareholderBuy77,842$5.16$401,664.72View SEC Filing  
5/24/2016Broadwood Partners LpMajor ShareholderBuy70,000$5.16$361,200.00View SEC Filing  
5/23/2016Broadwood Partners LpMajor ShareholderBuy3,138$5.24$16,443.12View SEC Filing  
5/20/2016Richard A MeierDirectorSell25,000$5.35$133,750.00View SEC Filing  
5/17/2016Broadwood Partners LpMajor ShareholderBuy9,313$5.23$48,706.99View SEC Filing  
5/16/2016Broadwood Partners LpMajor ShareholderBuy336,210$5.49$1,845,792.90View SEC Filing  
2/9/2016Broadwood Partners LpMajor ShareholderBuy91,770$6.25$573,562.50View SEC Filing  
2/3/2016Broadwood Partners LpMajor ShareholderBuy121,599$6.40$778,233.60View SEC Filing  
2/1/2016Broadwood Partners LpMajor ShareholderBuy65,983$6.48$427,569.84View SEC Filing  
1/27/2016Broadwood Partners LpMajor ShareholderBuy239,013$6.63$1,584,656.19View SEC Filing  
1/26/2016Broadwood Partners LpMajor ShareholderBuy112,900$6.60$745,140.00View SEC Filing  
1/25/2016Broadwood Partners LpMajor ShareholderBuy81,752$6.74$551,008.48View SEC Filing  
1/20/2016Broadwood Partners LpMajor ShareholderBuy72,858$6.75$491,791.50View SEC Filing  
1/15/2016Broadwood Partners LpMajor ShareholderBuy135,725$6.73$913,429.25View SEC Filing  
1/11/2016Broadwood Partners LpMajor ShareholderBuy86,586$6.83$591,382.38View SEC Filing  
1/7/2016Broadwood Partners LpMajor ShareholderBuy267,047$6.95$1,855,976.65View SEC Filing  
1/4/2016Broadwood Partners LpMajor ShareholderBuy165,461$7.11$1,176,427.71View SEC Filing  
9/29/2015Broadwood Partners LpMajor ShareholderBuy311,099$7.08$2,202,580.92View SEC Filing  
8/25/2015Broadwood Partners LpMajor ShareholderBuy188,881$7.17$1,354,276.77View SEC Filing  
8/24/2015Caren L MasonCEOBuy10,000$7.34$73,400.00View SEC Filing  
4/6/2015Samuel J GestenVPSell3,223$7.14$23,012.22View SEC Filing  
3/3/2015Robin HughesVPSell23,253$15.82$367,862.46View SEC Filing  
11/19/2014Broadwood Partners LpMajor ShareholderBuy189,646$8.64$1,638,541.44View SEC Filing  
11/18/2014Broadwood Partners LpMajor ShareholderBuy39,400$8.67$341,598.00View SEC Filing  
11/17/2014Broadwood Partners LpMajor ShareholderBuy118,200$8.63$1,020,066.00View SEC Filing  
11/10/2014Broadwood Partners LpMajor ShareholderBuy500$8.79$4,395.00View SEC Filing  
11/7/2014Broadwood Partners LpMajor ShareholderBuy80,000$8.92$713,600.00View SEC Filing  
11/4/2014Broadwood Partners LpMajor ShareholderBuy260,341$9.20$2,395,137.20View SEC Filing  
5/15/2014John MooreDirectorSell2,800$14.87$41,636.00View SEC Filing  
3/19/2014James FranceseVPSell16,666$17.22$286,988.52View SEC Filing  
3/17/2014Robin HughesVPSell5,672$16.61$94,211.92View SEC Filing  
9/4/2013Deborah AndrewsCFOSell50,000$12.88$644,000.00View SEC Filing  
8/20/2013Deborah AndrewsCFOSell33,515$11.65$390,449.75View SEC Filing  
8/12/2013Deborah AndrewsCFOSell9,079$11.62$105,497.98View SEC Filing  
8/7/2013Deborah AndrewsCFOSell11,721$11.79$138,190.59View SEC Filing  
5/9/2013Deborah J AndrewsCFOSell5,000$8.96$44,800.00View SEC Filing  
12/11/2012John C MooreDirectorBuy5,000$5.46$27,300.00View SEC Filing  
11/15/2012Broadwood Partners LpMajor ShareholderBuy2,618$5.00$13,090.00View SEC Filing  
11/15/2012Mark B LoganDirectorBuy3,600$5.22$18,792.00View SEC Filing  
11/14/2012Barry G CaldwellCEOBuy5,000$5.04$25,200.00View SEC Filing  
11/2/2012Broadwood Partners LpMajor ShareholderBuy22,572$5.00$112,860.00View SEC Filing  
8/9/2012Barry G CaldwellCEOBuy5,000$6.57$32,850.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Staar Surgical (NASDAQ:STAA)
DateHeadline logoSTAAR Surgical to Report Third Quarter Results on November 3, 2016 (NASDAQ:STAA) - October 20 at 7:46 PM
News IconAlcon, Abbott Medical Optics Lead Competitive Europe Interventional Ophthalmic Devices Market (NASDAQ:STAA) - October 19 at 7:06 PM logoSTAAR Surgical Shares Up 45.6% Since SmarTrend's Buy Recommendation (STAA) (NASDAQ:STAA) - October 16 at 11:46 AM logoSTAAR Surgical : MILITARY $1.03 Million Federal Contract Awarded to Staar Surgical (NASDAQ:STAA) - October 16 at 11:46 AM
News IconLack of General Awareness among People Regarding Eye Disorders Act as a Barrier for Ophthalmology Cataract Surgery Devices Market (NASDAQ:STAA) - October 14 at 10:46 AM logoWhat’s the Hottest Stocks in Manufacturing Sector? (NASDAQ:STAA) - October 11 at 12:45 PM
News Icon2021 Forecast: Global Premium Monofocal Lenses Market (NASDAQ:STAA) - October 6 at 7:12 PM logoSTAAR Surgical Has Returned 49.4% Since SmarTrend Recommendation (STAA) (NASDAQ:STAA) - September 30 at 6:49 PM
News IconSTAAR Surgical Announces Two Cooperation Agreements, Receives Health Canada Approval for Toric ICL (NASDAQ:STAA) - September 29 at 12:18 PM
News IconSTAAR Surgical receives approval of EVO Visian toric ICL from Health Canada (NASDAQ:STAA) - September 24 at 11:22 AM
News IconSTAAR Surgical receives Health Canada approval for EVO Visian ICL toric lens for nearsighted patient with astigmatism (NASDAQ:STAA) - September 24 at 11:22 AM
News IconStaar Surgical Announces Approval by Health Canada of Its EVO Visian ICL Toric Lens (NASDAQ:STAA) - September 22 at 7:07 PM logo50.2% Return Seen to Date on SmarTrend STAAR Surgical Call (STAA) (NASDAQ:STAA) - September 22 at 7:07 PM
News IconStaar Surgical wins Health Canada nod for Visian Toric ICL (NASDAQ:STAA) - September 22 at 7:07 PM logoSTAAR Surgical Announces Approval by Health... (NASDAQ:STAA) - September 22 at 7:07 PM logoSTAAR Surgical's (STAA) EVO Visian Toric ICL Approved in Canada (NASDAQ:STAA) - September 22 at 7:07 PM logoSTAAR Surgical Announces Approval by Health Canada of Its EVO Visian ICL™ Toric Lens Specifically Designed … (NASDAQ:STAA) - September 22 at 7:07 PM logoSTAAR SURGICAL CO : Regulation FD Disclosure (form 8-K) (NASDAQ:STAA) - September 22 at 7:07 PM logoChina Intraocular Lens Market 2016-2021 : Alcon Laboratories Inc., Abbott Medical Optics Inc, Bausch & Lomb Incorporated, STAAR Surgical AG, Rayner (NASDAQ:STAA) - September 21 at 11:35 AM
News IconStaar Surgical inks 44-hospital distribution deal in India (NASDAQ:STAA) - September 17 at 11:19 AM logoSTAAR Surgical : Announces Strategic Cooperation Agreement With World Eye Hospital Group (NASDAQ:STAA) - September 17 at 11:19 AM
News IconLeading Refractive Surgery Provider, Gurgaon, India And STAAR Surgical Announce Strategic Cooperation Agreement (NASDAQ:STAA) - September 16 at 11:01 AM logoContact Lenses 2016 Global Market Study and Analysis Research Report to 2022 (NASDAQ:STAA) - September 16 at 11:01 AM logoLeading Refractive Surgery Provider, EyeQ Vision Private Ltd., Gurgaon, India and STAAR Surgical Announce Strategic Cooperation Agreement (NASDAQ:STAA) - September 15 at 11:07 AM logoSTAAR SURGICAL CO Files SEC form 8-K, Regulation FD Disclosure (NASDAQ:STAA) - September 15 at 11:07 AM logoUptrend Call Working As STAAR Surgical Stock Rises 38.4% (STAA) (NASDAQ:STAA) - September 14 at 7:38 PM logoETF’s with exposure to STAAR Surgical Co. : September 14, 2016 (NASDAQ:STAA) - September 14 at 11:51 AM logoOphthalmology Cataract Surgery Devices: A Revolutionary Innovation That Redefines HC for Healthier Future (NASDAQ:STAA) - September 9 at 11:37 AM
News IconSTAAR Surgical Announces Strategic Cooperation Agreement With World Eye Hospital Group (NASDAQ:STAA) - September 7 at 11:13 AM logoUptrend Call Working As STAAR Surgical Stock Rises 40.8% (STAA) (NASDAQ:STAA) - August 30 at 7:23 PM
News IconSTAAR reports record net sales for quarter (NASDAQ:STAA) - August 24 at 10:41 AM logoUptrend Call Working As STAAR Surgical Stock Rises 46.4% (STAA) (NASDAQ:STAA) - August 24 at 10:41 AM logoSTAAR Surgical Has Returned 50.2% Since SmarTrend Recommendation (STAA) (NASDAQ:STAA) - August 15 at 7:58 PM logoETF’s with exposure to STAAR Surgical Co. : August 15, 2016 (NASDAQ:STAA) - August 15 at 7:58 PM logoSTAAR Surgical's (STAA) CEO Caren Mason on Q2 2016 Results - Earnings Call Transcript (NASDAQ:STAA) - August 4 at 10:48 AM logoEARNINGS SUMMARY: Details of STAAR Surgical Company Q2 Earnings Report (NASDAQ:STAA) - August 3 at 7:58 PM logoBRIEF-Staar Surgical reports second quarter 2016 results (NASDAQ:STAA) - August 3 at 7:58 PM logoStaar Surgical reports 2Q loss (NASDAQ:STAA) - August 3 at 7:58 PM logoSTAAR Surgical Co Earnings Call (Q2 2016) (NASDAQ:STAA) - August 3 at 10:51 AM logoQ2 2016 STAAR Surgical Co Earnings Release - After Market Close (NASDAQ:STAA) - August 3 at 10:51 AM
News IconNew report examines the contact lenses market 2016 global trends, market share, industry size, growth, opportunities, and market forecast to 2022 (NASDAQ:STAA) - August 1 at 11:46 AM
News IconGlobal contact lenses market is expected to grow at a CAGR of 3.67 % during the forecast period (NASDAQ:STAA) - July 27 at 8:00 PM logoNorth American Ophthalmology Surgery Devices Market Report 2016 - Opportunities and Forecasts 2014-2022 - Research and Markets (NASDAQ:STAA) - July 20 at 8:34 PM logoSTAAR Surgical to Report Second Quarter Results on August 3, 2016 (NASDAQ:STAA) - July 20 at 1:00 PM logoSHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Breaches of Delaware Law by the Board of STAAR Surgical Company (NASDAQ:STAA) - July 18 at 1:21 PM
News IconSTAAR reports $8 million net loss in first quarter (NASDAQ:STAA) - July 13 at 7:59 PM logoLong Term STAAR Investors: Shareholder Rights Law Firm Johnson & Weaver, LLP Initiates Investigation of STAAR Surgical Company; Encourages Long Term Investors to Contact the Firm (NASDAQ:STAA) - July 6 at 9:40 AM logoSTAAR SURGICAL CO Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote of S (NASDAQ:STAA) - June 27 at 2:06 PM
News IconGlobal contact lenses market 2016 share, trend, segmentation and forecast to 2022 insights shared in detailed report (NASDAQ:STAA) - June 25 at 6:57 PM logoSTAAR Surgical Company ("STAA") is the Subject of a Legal Investigation (NASDAQ:STAA) - June 24 at 10:53 AM


Staar Surgical (NASDAQ:STAA) Chart for Monday, October, 24, 2016

Last Updated on 10/24/2016 by Staff